Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Journal of Medicinal Chemistry
|
May 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin
W F Hoffman, A W Alberts, P S Anderson, et al.
Psychopharmacology
|
January 1, 1996
Movements in never-medicated schizophrenics: a preliminary study
D S Fenn, D Moussaoui, W F Hoffman, et al.
Journal of Medicinal Chemistry
|
July 1, 1981
(Acylaryloxy)acetic acid diuretics. 3. 2,3-Dihydro-5-acyl-2-benzofurancarboxylic acids, a new class of uricosuric diuretics
W F Hoffman, O W Woltersdorf, F C Novello, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 1990
Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse
K P Vyas, P H Kari, S M Pitzenberger, et al.
Journal of Medicinal Chemistry
|
February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives
G E Stokker, A W Alberts, P S Anderson, et al.
Journal of Medicinal Chemistry
|
March 1, 1985
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 1. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivatives
G E Stokker, W F Hoffman, A W Alberts, et al.
Journal of Medicinal Chemistry
|
February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives
W F Hoffman, A W Alberts, E J Cragoe, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 17, 1999
Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitors
G D Hartman, M E Duggan, W F Hoffman, et al.
Journal of Medicinal Chemistry
|
October 6, 2000
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist
M E Duggan, L T Duong, J E Fisher, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Journal of Medicinal Chemistry
|
May 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin
W F Hoffman, A W Alberts, P S Anderson, et al.
Psychopharmacology
|
January 1, 1996
Movements in never-medicated schizophrenics: a preliminary study
D S Fenn, D Moussaoui, W F Hoffman, et al.
Journal of Medicinal Chemistry
|
July 1, 1981
(Acylaryloxy)acetic acid diuretics. 3. 2,3-Dihydro-5-acyl-2-benzofurancarboxylic acids, a new class of uricosuric diuretics
W F Hoffman, O W Woltersdorf, F C Novello, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 1990
Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse
K P Vyas, P H Kari, S M Pitzenberger, et al.
Journal of Medicinal Chemistry
|
February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives
G E Stokker, A W Alberts, P S Anderson, et al.
Journal of Medicinal Chemistry
|
March 1, 1985
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 1. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivatives
G E Stokker, W F Hoffman, A W Alberts, et al.
Journal of Medicinal Chemistry
|
February 1, 1986
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives
W F Hoffman, A W Alberts, E J Cragoe, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 17, 1999
Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitors
G D Hartman, M E Duggan, W F Hoffman, et al.
Journal of Medicinal Chemistry
|
October 6, 2000
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist
M E Duggan, L T Duong, J E Fisher, et al.
Page
of 4